News

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

The companies belonging to the Zacks Utility-Electric Power industry present an attractive investment case, underpinned by stable cash flows and predictable earnings from regulated business models

Automation and robotics are steadily moving from experimentation into real-world deployment as advances in AI, compute and machine intelligence intersect with labor constraints and rising efficiency

Bristol Myers Squibb BMY recently collaborated with clinical-stage biopharma company Janux Therapeutics to jointly develop a novel, tumor-activated therapeutic targeting a validated solid tumor

Transdigm Group TDG is scheduled to release first-quarter fiscal 2026 results on Feb. 3, before market open. The company delivered an earnings surprise of 5.6% in the last reported quarter. Let’s

We expect investors to focus on Viking Therapeutics’ VKTX progress with the development of its lead candidate, VK2735, a dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent

Canadian National (CNI) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.3 per share a year ago. These

Flex Ltd FLEX is slated to report third-quarter fiscal 2026 results on Feb. 4.

The Zacks Consensus Estimate for fiscal third-quarter revenues is pegged at $6.81 billion, which indicates an increase

Bio-Techne Corporation TECH is set to release second-quarter fiscal 2026 results on Feb. 4, before the opening bell.

The life science and diagnostic product maker posted adjusted earnings per share

Lumen Technologies, Inc. LUMN is scheduled to report its fourth-quarter 2025 results on Feb. 3, after market close.

The Zacks Consensus Estimate for the bottom line in the to-be-reported quarter is

ChoiceOne Financial Services, Inc. (COFS) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.83 per share a

For Immediate Release

Chicago, IL – January 30, 2026 – Zacks Equity Research shares Intuitive Surgical, Inc. ISRG, as the Bull of the Day and KB Home KBH as the Bear of the Day. In addition, Zacks

Investors in Vista Energy, S.A.B. de C.V. VIST need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $25.00 Put had some of the

Shares of CorMedix CRMD have declined sharply over the past month, reflecting investor concerns following its bearish 2026 financial outlook. The guidance points to a more conservative growth

Investors in Nutanix, Inc. NTNX need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $105.00 Call had some of the highest implied

Investors in Carlyle Group CG need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $32.50 Call had some of the highest implied

Sandisk SNDK reported second-quarter fiscal 2026 non-GAAP earnings of $6.20 per share, which beat the Zacks Consensus Estimate by 75.14%. The company reported earnings of $1.23 per share in the

Investors in Enterprise Financial Services EFSC need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $35.00 Call had some of the

Apple AAPL reported first-quarter fiscal 2026 GAAP earnings of $2.84 per share, which beat the Zacks Consensus Estimate by 7.17%.Net sales increased 15.7% year over year to $143.77 billion and beat

The global cannabis market is rapidly evolving, with President Trump’s decision to federally reschedule marijuana in the United States representing one of the most consequential regulatory shifts in

Investors in Badger Meter, Inc. BMI need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 20, 2026 $340 Call had some of the highest implied